ClouDr Group Future Growth
Future criteria checks 2/6
ClouDr Group is forecast to grow earnings and revenue by 147.9% and 23.5% per annum respectively while EPS is expected to grow by 32.2% per annum.
Key information
147.9%
Earnings growth rate
32.2%
EPS growth rate
| Healthcare earnings growth | 27.5% |
| Revenue growth rate | 23.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5,751 | 46 | N/A | -107 | 2 |
| 12/31/2024 | 4,745 | -92 | N/A | -191 | 2 |
| 6/30/2024 | 4,013 | -283 | -402 | -282 | N/A |
| 3/31/2024 | 3,852 | -303 | -333 | -211 | N/A |
| 12/31/2023 | 3,691 | -323 | -263 | -140 | N/A |
| 9/30/2023 | 3,551 | -469 | -361 | -201 | N/A |
| 6/30/2023 | 3,411 | -614 | -459 | -261 | N/A |
| 3/31/2023 | 3,199 | -1,152 | -634 | -452 | N/A |
| 12/31/2022 | 2,988 | -1,689 | -810 | -643 | N/A |
| 9/30/2022 | 2,738 | -1,887 | -851 | -734 | N/A |
| 6/30/2022 | 2,430 | -2,844 | -866 | -809 | N/A |
| 3/31/2022 | 2,093 | -3,492 | -810 | -737 | N/A |
| 12/31/2021 | 1,757 | -4,139 | -755 | -666 | N/A |
| 9/30/2021 | 1,513 | -4,701 | -748 | -667 | N/A |
| 12/31/2020 | 839 | -2,867 | -479 | -438 | N/A |
| 12/31/2019 | 524 | -557 | -365 | -360 | N/A |
| 12/31/2018 | 250 | -140 | -196 | -195 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: H3L is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: H3L is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: H3L is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: H3L's revenue (23.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: H3L's revenue (23.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if H3L's Return on Equity is forecast to be high in 3 years time